Prevalence of opiophobia in cancer pain treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista Dor |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400245 |
Resumo: | ABSTRACT BACKGROUND AND OBJECTIVES: Pain depreciates patients' quality of life, even influencing disease recovery. This study aimed at evaluating the prevalence of pain and opiophobia as barrier for the adequate management of cancer pain. METHODS Participated in the study 280 cancer patients in clinical treatment, who have answered a questionnaire made up of questions related to pain and use of opioid drugs. Demographic and clinical data were obtained by reviewing medical charts. The study was individually and randomly applied by the authors during outpatient visits. RESULTS: Prevalence of pain was 50.3%; 19.2% of patients would refuse morphine for pain control and fear of dependence was the most reported reason. The perception that morphine is directly related to worsening the disease was reported by 67.8% of respondents. CONCLUSION: A high prevalence of moderate and severe pain was found among studied patients, as well as a high prevalence of opiophobia. |
id |
SBED-1_734107e476806dc9a33f7adfa44a0473 |
---|---|
oai_identifier_str |
oai:scielo:S1806-00132016000400245 |
network_acronym_str |
SBED-1 |
network_name_str |
Revista Dor |
repository_id_str |
|
spelling |
Prevalence of opiophobia in cancer pain treatmentChronic painFearMorphineOpioid analgesicsPainABSTRACT BACKGROUND AND OBJECTIVES: Pain depreciates patients' quality of life, even influencing disease recovery. This study aimed at evaluating the prevalence of pain and opiophobia as barrier for the adequate management of cancer pain. METHODS Participated in the study 280 cancer patients in clinical treatment, who have answered a questionnaire made up of questions related to pain and use of opioid drugs. Demographic and clinical data were obtained by reviewing medical charts. The study was individually and randomly applied by the authors during outpatient visits. RESULTS: Prevalence of pain was 50.3%; 19.2% of patients would refuse morphine for pain control and fear of dependence was the most reported reason. The perception that morphine is directly related to worsening the disease was reported by 67.8% of respondents. CONCLUSION: A high prevalence of moderate and severe pain was found among studied patients, as well as a high prevalence of opiophobia.Sociedade Brasileira para o Estudo da Dor2016-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400245Revista Dor v.17 n.4 2016reponame:Revista Dorinstname:Sociedade Brasileira para o Estudo da Dor (SBED)instacron:SBED10.5935/1806-0013.20160081info:eu-repo/semantics/openAccessCella,Igor FurlanTrindade,Lilian Cristine TeixeiraSanvido,Lucas VasconcelosSkare,Thelma Laroccaeng2017-01-03T00:00:00Zoai:scielo:S1806-00132016000400245Revistahttps://www.scielo.br/j/rdor/ONGhttps://old.scielo.br/oai/scielo-oai.phpdor@dor.org.br||dor@dor.org.br2317-63931806-0013opendoar:2017-01-03T00:00Revista Dor - Sociedade Brasileira para o Estudo da Dor (SBED)false |
dc.title.none.fl_str_mv |
Prevalence of opiophobia in cancer pain treatment |
title |
Prevalence of opiophobia in cancer pain treatment |
spellingShingle |
Prevalence of opiophobia in cancer pain treatment Cella,Igor Furlan Chronic pain Fear Morphine Opioid analgesics Pain |
title_short |
Prevalence of opiophobia in cancer pain treatment |
title_full |
Prevalence of opiophobia in cancer pain treatment |
title_fullStr |
Prevalence of opiophobia in cancer pain treatment |
title_full_unstemmed |
Prevalence of opiophobia in cancer pain treatment |
title_sort |
Prevalence of opiophobia in cancer pain treatment |
author |
Cella,Igor Furlan |
author_facet |
Cella,Igor Furlan Trindade,Lilian Cristine Teixeira Sanvido,Lucas Vasconcelos Skare,Thelma Larocca |
author_role |
author |
author2 |
Trindade,Lilian Cristine Teixeira Sanvido,Lucas Vasconcelos Skare,Thelma Larocca |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Cella,Igor Furlan Trindade,Lilian Cristine Teixeira Sanvido,Lucas Vasconcelos Skare,Thelma Larocca |
dc.subject.por.fl_str_mv |
Chronic pain Fear Morphine Opioid analgesics Pain |
topic |
Chronic pain Fear Morphine Opioid analgesics Pain |
description |
ABSTRACT BACKGROUND AND OBJECTIVES: Pain depreciates patients' quality of life, even influencing disease recovery. This study aimed at evaluating the prevalence of pain and opiophobia as barrier for the adequate management of cancer pain. METHODS Participated in the study 280 cancer patients in clinical treatment, who have answered a questionnaire made up of questions related to pain and use of opioid drugs. Demographic and clinical data were obtained by reviewing medical charts. The study was individually and randomly applied by the authors during outpatient visits. RESULTS: Prevalence of pain was 50.3%; 19.2% of patients would refuse morphine for pain control and fear of dependence was the most reported reason. The perception that morphine is directly related to worsening the disease was reported by 67.8% of respondents. CONCLUSION: A high prevalence of moderate and severe pain was found among studied patients, as well as a high prevalence of opiophobia. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400245 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400245 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5935/1806-0013.20160081 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira para o Estudo da Dor |
publisher.none.fl_str_mv |
Sociedade Brasileira para o Estudo da Dor |
dc.source.none.fl_str_mv |
Revista Dor v.17 n.4 2016 reponame:Revista Dor instname:Sociedade Brasileira para o Estudo da Dor (SBED) instacron:SBED |
instname_str |
Sociedade Brasileira para o Estudo da Dor (SBED) |
instacron_str |
SBED |
institution |
SBED |
reponame_str |
Revista Dor |
collection |
Revista Dor |
repository.name.fl_str_mv |
Revista Dor - Sociedade Brasileira para o Estudo da Dor (SBED) |
repository.mail.fl_str_mv |
dor@dor.org.br||dor@dor.org.br |
_version_ |
1752126255431417856 |